Childhood Leukemias
Herausgeber: Pui, Ching-Hon
Childhood Leukemias
Herausgeber: Pui, Ching-Hon
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
The most comprehensive, clinically-oriented and authoritative reference dedicated to these diseases, from basic science to clinical management.
Andere Kunden interessierten sich auch für
- Juan M PascualProgressive Brain Disorders in Childhood126,99 €
- Acute Leukemias II83,99 €
- Hematologic Malignancies: Acute Leukemias161,99 €
- Acute Leukemias IV75,99 €
- Acute Leukemias V42,99 €
- Small Volume Biopsy in Pediatric Tumors148,99 €
- Acute Leukemias VIII43,99 €
-
-
-
The most comprehensive, clinically-oriented and authoritative reference dedicated to these diseases, from basic science to clinical management.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- 3rd Revised edition
- Seitenzahl: 892
- Erscheinungstermin: 30. Juli 2012
- Englisch
- Abmessung: 277mm x 226mm x 46mm
- Gewicht: 2699g
- ISBN-13: 9780521196611
- ISBN-10: 0521196612
- Artikelnr.: 33352731
- Verlag: Cambridge University Press
- 3rd Revised edition
- Seitenzahl: 892
- Erscheinungstermin: 30. Juli 2012
- Englisch
- Abmessung: 277mm x 226mm x 46mm
- Gewicht: 2699g
- ISBN-13: 9780521196611
- ISBN-10: 0521196612
- Artikelnr.: 33352731
Preface; Part I. History and General Issues: 1. History of leukemia Paul
Gaynon, Toska Zomorodian and Donald Pinkel; 2. Diagnosis and classification
Mihaela Onciu and Ching-Hon Pui; 3. Epidemiology and etiology Logan
Spector, Bridget Charbonneau and Leslie L. Robison; Part II. Cell Biology
and Pathobiology: 4. Immunophenotyping Fred G. Behm; 5. Immunoglobulin and
T-cell receptor gene rearrangements Jacques J. M. van Dongen and Anton W.
Langerak; 6. Cytogenetics of acute leukemias Susana C. Raimondi; 7.
Molecular genetics of acute lymphoblastic leukemias Charles Mullighan; 8.
Molecular genetics of acute myeloid leukemia Tanja A. Gruber and James R.
Downing; 9. Epigenetics of leukemias William Stevenson and Guillermo
Garcia-Manero; 10. Genetics and cellular drug resistance in acute leukemia
Monique L. den Boer and Rob Pieters; 11. Heritable predispositions to
childhood hematologic malignancies Doan Le, Kevin Shannon and Beverly J.
Lange; Part III. Evaluation and Treatment: 12. Pharmacokinetic,
pharmacodynamic, and pharmacogenetic considerations Stephen W. Paugh, Mary
V. Relling and Williams E. Evans; 13. Acute lymphoblastic leukemia
Ching-Hon Pui; 14. Relapsed acute lymphoblastic leukemia Günter Henze and
Arend von Stackelberg; 15. B-cell acute lymphoblastic leukemia and Burkitt
lymphoma John T. Sandlund and Mihaela Onciu; 16. Acute myeloid leukemia
Jeffrey E. Rubnitz, Hiroto Inaba and Raul Ribeiro; 17. Relapsed acute
myeloid leukemia Ursula Creutzig; 18. Myelodysplastic syndromes Henrik
Hasle; 19. Chronic myeloproliferative disorders Charlotte M. Niemeyer and
Franco Locatelli; 20. Leukemias in patients with Down syndrome Jeffrey W.
Taub, April Sorrell and James A. Whitlock; 21. Treatment of adolescents and
young adults with acute lymphoblastic leukemia James Nachman; 22.
Hematopoietic stem cell and natural killer cell transplantation Wing Leung
and Michael A. Pulsipher; 23. Treatment in the underprivileged countries
Raul Ribeiro, Scott C. Howard and Ching-Hon Pui; 24. Antibody-targeted
therapy Alan S. Wayne; 25. Adoptive cellular immunotherapy Hyoung Jin Kang,
Cliona M. Rooney and Helen Heslop; 26. Gene therapy: methods and
applications Ulrike Gerdemann, Martin Pulé and Malcolm K. Brenner; 27.
Development therapeutics Sima Jeha; 28. Minimal residual disease Dario
Campana, Andrea Biondi and Jacques J. M. van Dongen; Part IV. Complications
and Supportive Care: 29. Acute complications Scott C. Howard, Raul Ribeiro
and Ching-Hon Pui; 30. Late complications after leukemia therapy Melissa
Hudson; 31. Therapy-related leukemias Carolyn A. Felix; 32. Infectious
complications Hana Hakim and Patricia M. Flynn; 33. Hematologic supportive
care Fariba Navid and Victor M. Santana; 34. Pain management Doralina L.
Anghelescu and Roland Kaddoum; 35. Psychosocial issues Sean Phipps, Vida L.
Tyc, Heather Conklin and Kevin Krull; 36. Nursing care Jami S. Gattuso,
Martha May and Michele Pritchard; Index.
Gaynon, Toska Zomorodian and Donald Pinkel; 2. Diagnosis and classification
Mihaela Onciu and Ching-Hon Pui; 3. Epidemiology and etiology Logan
Spector, Bridget Charbonneau and Leslie L. Robison; Part II. Cell Biology
and Pathobiology: 4. Immunophenotyping Fred G. Behm; 5. Immunoglobulin and
T-cell receptor gene rearrangements Jacques J. M. van Dongen and Anton W.
Langerak; 6. Cytogenetics of acute leukemias Susana C. Raimondi; 7.
Molecular genetics of acute lymphoblastic leukemias Charles Mullighan; 8.
Molecular genetics of acute myeloid leukemia Tanja A. Gruber and James R.
Downing; 9. Epigenetics of leukemias William Stevenson and Guillermo
Garcia-Manero; 10. Genetics and cellular drug resistance in acute leukemia
Monique L. den Boer and Rob Pieters; 11. Heritable predispositions to
childhood hematologic malignancies Doan Le, Kevin Shannon and Beverly J.
Lange; Part III. Evaluation and Treatment: 12. Pharmacokinetic,
pharmacodynamic, and pharmacogenetic considerations Stephen W. Paugh, Mary
V. Relling and Williams E. Evans; 13. Acute lymphoblastic leukemia
Ching-Hon Pui; 14. Relapsed acute lymphoblastic leukemia Günter Henze and
Arend von Stackelberg; 15. B-cell acute lymphoblastic leukemia and Burkitt
lymphoma John T. Sandlund and Mihaela Onciu; 16. Acute myeloid leukemia
Jeffrey E. Rubnitz, Hiroto Inaba and Raul Ribeiro; 17. Relapsed acute
myeloid leukemia Ursula Creutzig; 18. Myelodysplastic syndromes Henrik
Hasle; 19. Chronic myeloproliferative disorders Charlotte M. Niemeyer and
Franco Locatelli; 20. Leukemias in patients with Down syndrome Jeffrey W.
Taub, April Sorrell and James A. Whitlock; 21. Treatment of adolescents and
young adults with acute lymphoblastic leukemia James Nachman; 22.
Hematopoietic stem cell and natural killer cell transplantation Wing Leung
and Michael A. Pulsipher; 23. Treatment in the underprivileged countries
Raul Ribeiro, Scott C. Howard and Ching-Hon Pui; 24. Antibody-targeted
therapy Alan S. Wayne; 25. Adoptive cellular immunotherapy Hyoung Jin Kang,
Cliona M. Rooney and Helen Heslop; 26. Gene therapy: methods and
applications Ulrike Gerdemann, Martin Pulé and Malcolm K. Brenner; 27.
Development therapeutics Sima Jeha; 28. Minimal residual disease Dario
Campana, Andrea Biondi and Jacques J. M. van Dongen; Part IV. Complications
and Supportive Care: 29. Acute complications Scott C. Howard, Raul Ribeiro
and Ching-Hon Pui; 30. Late complications after leukemia therapy Melissa
Hudson; 31. Therapy-related leukemias Carolyn A. Felix; 32. Infectious
complications Hana Hakim and Patricia M. Flynn; 33. Hematologic supportive
care Fariba Navid and Victor M. Santana; 34. Pain management Doralina L.
Anghelescu and Roland Kaddoum; 35. Psychosocial issues Sean Phipps, Vida L.
Tyc, Heather Conklin and Kevin Krull; 36. Nursing care Jami S. Gattuso,
Martha May and Michele Pritchard; Index.
Preface; Part I. History and General Issues: 1. History of leukemia Paul
Gaynon, Toska Zomorodian and Donald Pinkel; 2. Diagnosis and classification
Mihaela Onciu and Ching-Hon Pui; 3. Epidemiology and etiology Logan
Spector, Bridget Charbonneau and Leslie L. Robison; Part II. Cell Biology
and Pathobiology: 4. Immunophenotyping Fred G. Behm; 5. Immunoglobulin and
T-cell receptor gene rearrangements Jacques J. M. van Dongen and Anton W.
Langerak; 6. Cytogenetics of acute leukemias Susana C. Raimondi; 7.
Molecular genetics of acute lymphoblastic leukemias Charles Mullighan; 8.
Molecular genetics of acute myeloid leukemia Tanja A. Gruber and James R.
Downing; 9. Epigenetics of leukemias William Stevenson and Guillermo
Garcia-Manero; 10. Genetics and cellular drug resistance in acute leukemia
Monique L. den Boer and Rob Pieters; 11. Heritable predispositions to
childhood hematologic malignancies Doan Le, Kevin Shannon and Beverly J.
Lange; Part III. Evaluation and Treatment: 12. Pharmacokinetic,
pharmacodynamic, and pharmacogenetic considerations Stephen W. Paugh, Mary
V. Relling and Williams E. Evans; 13. Acute lymphoblastic leukemia
Ching-Hon Pui; 14. Relapsed acute lymphoblastic leukemia Günter Henze and
Arend von Stackelberg; 15. B-cell acute lymphoblastic leukemia and Burkitt
lymphoma John T. Sandlund and Mihaela Onciu; 16. Acute myeloid leukemia
Jeffrey E. Rubnitz, Hiroto Inaba and Raul Ribeiro; 17. Relapsed acute
myeloid leukemia Ursula Creutzig; 18. Myelodysplastic syndromes Henrik
Hasle; 19. Chronic myeloproliferative disorders Charlotte M. Niemeyer and
Franco Locatelli; 20. Leukemias in patients with Down syndrome Jeffrey W.
Taub, April Sorrell and James A. Whitlock; 21. Treatment of adolescents and
young adults with acute lymphoblastic leukemia James Nachman; 22.
Hematopoietic stem cell and natural killer cell transplantation Wing Leung
and Michael A. Pulsipher; 23. Treatment in the underprivileged countries
Raul Ribeiro, Scott C. Howard and Ching-Hon Pui; 24. Antibody-targeted
therapy Alan S. Wayne; 25. Adoptive cellular immunotherapy Hyoung Jin Kang,
Cliona M. Rooney and Helen Heslop; 26. Gene therapy: methods and
applications Ulrike Gerdemann, Martin Pulé and Malcolm K. Brenner; 27.
Development therapeutics Sima Jeha; 28. Minimal residual disease Dario
Campana, Andrea Biondi and Jacques J. M. van Dongen; Part IV. Complications
and Supportive Care: 29. Acute complications Scott C. Howard, Raul Ribeiro
and Ching-Hon Pui; 30. Late complications after leukemia therapy Melissa
Hudson; 31. Therapy-related leukemias Carolyn A. Felix; 32. Infectious
complications Hana Hakim and Patricia M. Flynn; 33. Hematologic supportive
care Fariba Navid and Victor M. Santana; 34. Pain management Doralina L.
Anghelescu and Roland Kaddoum; 35. Psychosocial issues Sean Phipps, Vida L.
Tyc, Heather Conklin and Kevin Krull; 36. Nursing care Jami S. Gattuso,
Martha May and Michele Pritchard; Index.
Gaynon, Toska Zomorodian and Donald Pinkel; 2. Diagnosis and classification
Mihaela Onciu and Ching-Hon Pui; 3. Epidemiology and etiology Logan
Spector, Bridget Charbonneau and Leslie L. Robison; Part II. Cell Biology
and Pathobiology: 4. Immunophenotyping Fred G. Behm; 5. Immunoglobulin and
T-cell receptor gene rearrangements Jacques J. M. van Dongen and Anton W.
Langerak; 6. Cytogenetics of acute leukemias Susana C. Raimondi; 7.
Molecular genetics of acute lymphoblastic leukemias Charles Mullighan; 8.
Molecular genetics of acute myeloid leukemia Tanja A. Gruber and James R.
Downing; 9. Epigenetics of leukemias William Stevenson and Guillermo
Garcia-Manero; 10. Genetics and cellular drug resistance in acute leukemia
Monique L. den Boer and Rob Pieters; 11. Heritable predispositions to
childhood hematologic malignancies Doan Le, Kevin Shannon and Beverly J.
Lange; Part III. Evaluation and Treatment: 12. Pharmacokinetic,
pharmacodynamic, and pharmacogenetic considerations Stephen W. Paugh, Mary
V. Relling and Williams E. Evans; 13. Acute lymphoblastic leukemia
Ching-Hon Pui; 14. Relapsed acute lymphoblastic leukemia Günter Henze and
Arend von Stackelberg; 15. B-cell acute lymphoblastic leukemia and Burkitt
lymphoma John T. Sandlund and Mihaela Onciu; 16. Acute myeloid leukemia
Jeffrey E. Rubnitz, Hiroto Inaba and Raul Ribeiro; 17. Relapsed acute
myeloid leukemia Ursula Creutzig; 18. Myelodysplastic syndromes Henrik
Hasle; 19. Chronic myeloproliferative disorders Charlotte M. Niemeyer and
Franco Locatelli; 20. Leukemias in patients with Down syndrome Jeffrey W.
Taub, April Sorrell and James A. Whitlock; 21. Treatment of adolescents and
young adults with acute lymphoblastic leukemia James Nachman; 22.
Hematopoietic stem cell and natural killer cell transplantation Wing Leung
and Michael A. Pulsipher; 23. Treatment in the underprivileged countries
Raul Ribeiro, Scott C. Howard and Ching-Hon Pui; 24. Antibody-targeted
therapy Alan S. Wayne; 25. Adoptive cellular immunotherapy Hyoung Jin Kang,
Cliona M. Rooney and Helen Heslop; 26. Gene therapy: methods and
applications Ulrike Gerdemann, Martin Pulé and Malcolm K. Brenner; 27.
Development therapeutics Sima Jeha; 28. Minimal residual disease Dario
Campana, Andrea Biondi and Jacques J. M. van Dongen; Part IV. Complications
and Supportive Care: 29. Acute complications Scott C. Howard, Raul Ribeiro
and Ching-Hon Pui; 30. Late complications after leukemia therapy Melissa
Hudson; 31. Therapy-related leukemias Carolyn A. Felix; 32. Infectious
complications Hana Hakim and Patricia M. Flynn; 33. Hematologic supportive
care Fariba Navid and Victor M. Santana; 34. Pain management Doralina L.
Anghelescu and Roland Kaddoum; 35. Psychosocial issues Sean Phipps, Vida L.
Tyc, Heather Conklin and Kevin Krull; 36. Nursing care Jami S. Gattuso,
Martha May and Michele Pritchard; Index.